Cargando…
Global inactivation of carboxylesterase 1 (Ces1/Ces1g) protects against atherosclerosis in Ldlr(−/−) mice
Atherosclerotic cardiovascular disease is a leading cause of death in the western world. Increased plasma triglyceride and cholesterol levels are major risk factors for this disease. Carboxylesterase 1 (Ces1/Ces1g) has been shown to play a role in metabolic control. So far, the role of mouse Ces1/Ce...
Autores principales: | Xu, Jiesi, Xu, Yang, Xu, Yanyong, Yin, Liya, Zhang, Yanqiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5736751/ https://www.ncbi.nlm.nih.gov/pubmed/29259301 http://dx.doi.org/10.1038/s41598-017-18232-x |
Ejemplares similares
-
Regulation of carboxylesterase 1 (CES1) in human adipose tissue
por: Jernås, Margareta, et al.
Publicado: (2009) -
Carboxylesterase 1d (Ces1d) does not contribute to cholesteryl ester hydrolysis in the liver
por: Lian, Jihong, et al.
Publicado: (2021) -
Carboxylesterase 1 Is Regulated by Hepatocyte Nuclear Factor 4α and Protects Against Alcohol- and MCD diet-induced Liver Injury
por: Xu, Jiesi, et al.
Publicado: (2016) -
Hepatic Carboxylesterase 1 Is Induced by Glucose and Regulates Postprandial Glucose Levels
por: Xu, Jiesi, et al.
Publicado: (2014) -
Population Pharmacokinetics of Methylphenidate in Healthy Adults Emphasizing Novel and Known Effects of Several Carboxylesterase 1 (CES1) Variants
por: Lyauk, YK, et al.
Publicado: (2016)